Checkmate Pharmaceuticals's total assets for Q were $66.94M, a decrease of -15.09% from the previous quarter. CMPI total liabilities were $11.94M for the fiscal quarter, a 27.33% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.